unknown
Stage
About
Cellsway develops a microfluidic circulating tumor cell (CTC) liquid biopsy platform for minimally invasive cancer monitoring and patient profiling from blood samples.
Explore Cellsway's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.